DENALI THERAPEUTICS INC
DNLI·24823R105·US·Common Stock·Healthcare - Biotechnology-13D/G
DNLI (DENALI THERAPEUTICS INC) is held by 138 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($250.3M), BAILLIE GIFFORD & CO ($231.7M), Temasek Holdings (Private) Ltd ($134.6M). Net institutional sentiment: Mixed.
138
Holders
(12 Elite)
$2.3B
Total Value
66% (137)
Consensus
90 buying - 47 selling
13F: Insider & Congress:
Who's Trading
ActivistTRT. Rowe Price Investment Management, Inc.10.2%Jul 8, 2026
ActivistTRT. Rowe Price Investment Management, Inc.5.4%May 15, 2026
InsiderWJWatts Ryan J.Sell $581KJan 6, 2026
InsiderSOSchuth Alexander O.Sell $284KJan 6, 2026
InsiderHCHo CaroleSell $12KAug 13, 2025
InsiderSOSchuth Alexander O.Sell $40KAug 12, 2025
InsiderHCHo CaroleSell $40KAug 12, 2025
Showing 1-20 of 149
1 / 8
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer